As reported by IPWatchdog, Moderna is facing lawsuits in the United States from biotech firms, Arbutus Biopharma Corporation and Genevant Sciences GmbH.
Both companies allege that Moderna has infringed six of their U.S. patents relating to lipid nanoparticle (“LNP”) delivery technology. LNP delivery systems are crucial for mRNA therapies like Moderna’s COVID-19 vaccine by allowing treatments to bypass the human immune system without being destroyed.
Moderna has reportedly denied all allegations and vowed to vigorously defend itself against the claims made against it in court.
The plaintiffs in this action are seeking compensation, rather than an injunction, which is typically sought in such actions. If infringement is found, compensation through damages would likely be assessed through a “reasonable royalty”.
As reported by Reuters, three former employees of Taiwan Semiconductor Manufacturing Company ("TSMC") were charged with violating security law and other offences in Taiwan. The prosecutors have…
As reported by Reuters, the 9th US Circuit Court of Appeals has reinstated an $81 million award against Boeing, in a suit brought by Zunum Aero, an aircraft startup, accusing Boeing of stealing trade…
As reported by Mason Hayes & Curran, the Federal Court of Australia has reportedly found the supermarket chain, Aldi, liable for copyright infringement regarding illustrations used on the…
Carnegie Hall has reportedly commenced an action against Carnegie Diner and Café for trademark infringement.In its complaint filed with the United States District Court, Southern District of New York…
In Bell Canada et al. v. Millennium Funding, Inc. et al., 2025 FCA 153, Bell Canada and Bell Aliant (collectively, “Bell”) appealed an order granting the Respondents’ (collectively, “Millenium…
Goyard, the Parisian brand established in 1853 and still privately owned, has reportedly faced a surge in counterfeit bags flooding the market. The company refrains from advertising, avoids e-commerce…
